The Global Treatment Access Group (GTAG) is a working group of Canadian civil society organizations sharing information and undertaking joint activities aimed at improving access to essential medicines and other aspects of prevention and care, treatment and support for people living with HIV and AIDS in developing countries.
GTAG Platform: The Global AIDS Crisis: Five Steps Canada Should Take
GTAG Platform 2008: The Global AIDS Crisis: Four Steps for Canada
GTAG Letters to Government and Responses
World AIDS Day letter to the Prime Minister, December 2008
In lead up to World AIDS Day on December 1, 2008, the Global Treatment Access Group (GTAG) sent a letter to Prime Minister Stephen Harper, urging him to honour Canada's international commitment to help achieve universal access to HIV prevention, care and treatment by 2010, and highlighting some important steps for Canada to follow. The letter was endorsed by 45 NGOs and ASOs from across the country.
Reply from the Office of the Prime Minister re: World AIDS Day Letter 2008
Reply from the Office of the Finance Minister re: World AIDS Day Letter 2008
Letter to Minister Beverley J. Oda: G8 Development Meeting, April 2008
In lead up to the G8 Development Ministers meeting on April 5th-6th, The Global Treatment Access Group (GTAG) sent a letter to the Honourable Beverly J. Oda, Minister of International Cooperation. The letter included recommendations on how Canada can provide a comprehensive and effective response to addressing HIV and AIDS. The letter was endorsed by 28 NGO's and ASO's from across the country.
Take action on GTAG platform issues:
Canadian Access to Medicines Regime (CAMR)
In 2004, Canada introduced the Canadian Access to Medicines Regime (CAMR), legislation that was intended to help developing countries get more affordable medicines to their people. Since its adoption, CAMR has only been applied once because, despite its positive intention, the law is seriously flawed.
GTAG member Canadian HIV/AIDS Legal Network is a leading advocate for CAMR reform. Learn more and see how you can take action at http://www.aidslaw.ca/EN/camr/index.htm.
